Knowledge (XXG)

Cabazitaxel

Source 📝

553: 530: 619: 31: 3139: 778:
25 mg/m (C25) is superior to docetaxel 75 mg/m (D75) in terms of OS in patients with chemotherapy-naïve mCRPC. However, C20 and C25 did not demonstrate superiority for OS versus D75 in people with chemotherapy-naïve mCRPC. Cabazitaxel and docetaxel demonstrated different toxicity profiles, and C20 showed the overall lowest toxicity. In a
661:
InChI=1S/C45H57NO14/c1-24-28(57-39(51)33(48)32(26-17-13-11-14-18-26)46-40(52)60-41(3,4)5)22-45(53)37(58-38(50)27-19-15-12-16-20-27)35-43(8,36(49)34(55-10)31(24)42(45,6)7)29(54-9)21-30-44(35,23-56-30)59-25(2)47/h11-20,28-30,32-35,37,48,53H,21-23H2,1-10H3,(H,46,52)/t28-,29-,30+,32-,33+,34+,35-,37-,43+,44-,45+/m0/s1
777:
In people with metastatic castration-resistant prostate cancer (mCRPC), overall survival (OS) is markedly enhanced with cabazitaxel versus mitoxantrone after prior docetaxel treatment. FIRSTANA (ClinicalTrials.gov identifier: NCT01308567) assessed whether cabazitaxel 20 mg/m (C20) or
768:
Taxanes enhance microtubule stabilization and inhibit cellular mitosis and division. Moreover, taxanes prevent androgen receptor (AR) signaling by binding cellular microtubules and the microtubule-associated motor protein dynein, thus averting AR nuclear translocation.
1388:
for "Cabazitaxel Versus the Switch to Alternative AR-targeted Agent (Enzalutamide or Abiraterone) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients Previously Treated With Docetaxel and Who Rapidly Failed a Prior AR-targeted Agent (CARD)" at
1164:
Oudard S, Fizazi K, Sengeløv L, Daugaard G, Saad F, Hansen S, et al. (October 2017). "Cabazitaxel Versus Docetaxel As First-Line Therapy for Patients With Metastatic Castration-Resistant Prostate Cancer: A Randomized Phase III Trial-FIRSTANA".
822:
Cabazitaxel is metabolized in the liver by , which result in seven plasma metabolites and excreted 20 metabolites. During 14 days after administration, 80% of cabazitaxel is excreted: 76% in the feces and 3.7% as a renal excretion.
794:(81.7%) than mitoxantrone (58%). Common adverse effects with cabazitaxel include neutropenia (including febrile neutropenia) and GIT side effects appeared mainly in diarrhea, whereas, neuropathy was rarely detected. 208: 163: 677: 1417: 1267:"Phase I and pharmacokinetic study of XRP6258 (RPR 116258A), a novel taxane, administered as a 1-hour infusion every 3 weeks in patients with advanced solid tumors" 973: 61: 308:)-4-(Acetyloxy)-15-{amino}-2-hydroxy-3-phenylpropanoyl]oxy}-1-hydroxy-9,12-dimethoxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracycloheptadec-13-en-2-yl benzoate 2117: 633: 1376:
for "Cabazitaxel at 20 mg/m² Compared to 25 mg/m² With Prednisone for the Treatment of Metastatic Castration Resistant Prostate Cancer (PROSELICA)" at
3093: 1410: 1046: 783: 2700: 1852: 1808: 1686: 1017: 1611: 1364:
for "XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate Cancer (TROPIC)" at
1117:"Taxane-induced blockade to nuclear accumulation of the androgen receptor predicts clinical responses in metastatic prostate cancer" 653: 1403: 874: 3159: 2333: 2127: 264: 193: 93: 2746: 1748: 1638: 932:. U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute. February 2, 2011. 2668: 2651: 2526: 2290: 1668: 3129: 2400: 1996: 1023: 949: 725: 422: 786:, median survival was 15.1 months for participants receiving cabazitaxel versus 12.7 months for participants receiving 112: 3164: 3110: 2602: 1395: 779: 509: 802:
Cabazitaxel administration causes a decrease in plasma concentrations showing triphasic kinetics: a mean half life (t
3189: 1782: 2968: 2848: 2838: 3174: 3020: 2953: 2923: 2541: 1791: 371: 1200: 3179: 3098: 3005: 2823: 2538: 2024: 1872: 1799: 943: 149: 548: 2903: 2893: 2626: 2468: 498: 841:"FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)" 2175: 1992: 1962: 1822: 745: 362: 2573: 2450: 1971: 1887: 840: 641:
CO1C2OC2(OC(C)=O)2(OC(=O)c3ccccc3)3(O)C(OC(=O)(O)(NC(=O)OC(C)(C)C)c4ccccc4)C(C)=C((OC)C(=O)12C)C3(C)C
525: 3169: 2858: 2758: 2737: 2458: 2280: 2112: 1843: 1739: 1115:
Darshan MS, Loftus MS, Thadani-Mulero M, Levy BP, Escuin D, Zhou XK, et al. (September 2011).
317: 1916: 1390: 1377: 1365: 1097: 733: 123: 3065: 1216:"Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer" 1946: 1926: 1911: 3040: 2614: 1448: 1337: 1288: 1247: 1182: 1146: 1089: 478: 221: 43: 1308:"The role of cabazitaxel in the treatment of metastatic castration-resistant prostate cancer" 411: 3184: 3045: 2802: 2517: 2151: 2136: 1857: 1327: 1319: 1278: 1237: 1227: 1174: 1136: 1128: 1081: 899: 565: 326: 996:"Jevtana (cabazitaxel) Injection Approved by U.S. FDA After Priority Review - Jun 17, 2010" 431: 3143: 2484: 2446: 2237: 1659: 1574: 1265:
Mita AC, Denis LJ, Rowinsky EK, Debono JS, Goetz AD, Ochoa L, et al. (January 2009).
753: 729: 1201:"Cabazitaxel Effective for Hormone Refractory Prostate Cancer After Failure of Taxotere" 995: 552: 529: 3104: 2638: 2229: 1723: 1587: 1474: 1444: 1431: 1332: 1307: 1242: 1215: 1141: 1116: 721: 714: 925: 3153: 2978: 2938: 2308: 2181: 2062: 2005: 1763: 1712: 541: 234: 85: 1101: 351: 3025: 2989: 2873: 2863: 2817: 2813: 2775: 2683: 2473: 2412: 2408: 2389: 2384: 2363: 2352: 2166: 2160: 2146: 2141: 2072: 2067: 2020: 1906: 1773: 1753: 1682: 1631: 1621: 1435: 1427: 1072:
Jordan MA, Wilson L (April 2004). "Microtubules as a target for anticancer drugs".
787: 176: 171: 71: 1384: 1372: 1360: 1283: 1266: 1132: 3070: 3050: 3035: 3030: 3015: 2973: 2943: 2883: 2853: 2797: 2770: 2643: 2584: 2556: 2546: 2499: 2463: 2379: 2341: 2323: 2318: 2298: 2275: 2246: 2224: 2204: 2194: 2045: 2030: 2010: 1896: 1827: 1813: 1768: 1701: 1696: 1673: 1648: 1616: 1559: 1499: 1484: 1479: 1464: 791: 706: 156: 79: 3060: 2963: 2958: 2933: 2928: 2918: 2913: 2908: 2878: 2868: 2833: 2828: 2808: 2763: 2751: 2726: 2721: 2711: 2693: 2688: 2678: 2673: 2631: 2619: 2607: 2579: 2566: 2561: 2531: 2494: 2489: 2427: 2422: 2368: 2313: 2265: 2251: 2199: 2186: 2155: 2088: 2077: 2050: 2040: 2035: 1981: 1936: 1931: 1832: 1796: 1728: 1718: 1707: 1691: 1643: 1626: 1602: 1554: 1542: 1494: 749: 595: 402: 1323: 1178: 3075: 3055: 3010: 3000: 2994: 2898: 2843: 2792: 2716: 2706: 2661: 2648: 2589: 2551: 2479: 2417: 2358: 2347: 2303: 2260: 2219: 2213: 2209: 2171: 2098: 2093: 2083: 2055: 2015: 1976: 1951: 1941: 1901: 1547: 1537: 1532: 1527: 1489: 974:"Jevtana (cabazitaxel) Injection Approved by U.S. FDA After Priority Review" 757: 65: 22: 1341: 1292: 1251: 1186: 1150: 1093: 2984: 2948: 2888: 2656: 2594: 2374: 2270: 2242: 1921: 1758: 382: 107: 1232: 391: 30: 1877: 1778: 1592: 1453: 337: 1517: 710: 702: 489: 1085: 458: 451: 618: 609: 469: 442: 243: 215: 1399: 228: 102: 848: 514: 202: 134: 944:"Drug Approval Package: Jevtana (Cabazitaxel) NDA #201023" 684: 3127: 752:
for the treatment of metastatic castration-resistant
2785: 2736: 2516: 2509: 2445: 2399: 2332: 2289: 2126: 2111: 1991: 1961: 1886: 1871: 1842: 1738: 1658: 1601: 1584: 1573: 1509: 1462: 1443: 869: 867: 865: 607: 594: 564: 559: 540: 508: 488: 468: 441: 421: 401: 381: 370: 361: 336: 316: 255: 192: 187: 162: 148: 122: 92: 78: 60: 52: 42: 37: 1306:Tsao CK, Cutting E, Martin J, Oh WK (June 2014). 790:. Cabazitaxel was associated with more grade 3–4 350: 325: 976:(Press release). Sanofi Aventis. June 17, 2010 728:(FDA) for the treatment of hormone-refractory 701:, is a semi-synthetic derivative of a natural 1411: 8: 111: 21: 2513: 2123: 1883: 1598: 1581: 1459: 1418: 1404: 1396: 810:of 1.3 h in the second phase, and a mean t 551: 528: 410: 29: 1331: 1282: 1241: 1231: 1140: 806:) of 2.6 min in the first phase, a mean t 430: 1214:Paller CJ, Antonarakis ES (March 2011). 3134: 832: 658: 638: 524: 390: 269: 84: 998:(Press release). Sanofi. June 17, 2010 542: 20: 497: 477: 70: 7: 1220:Drug Design, Development and Therapy 784:castration-resistant prostate cancer 175: 1687:ribonucleotide reductase inhibitors 732:in June 2010. It is available as a 457: 450: 341: 1853:Ribonucleotide reductase inhibitor 1809:Ribonucleotide reductase inhibitor 782:with 755 men for the treatment of 14: 1612:Dihydrofolate reductase inhibitor 1051:U.S. Food and Drug Administration 1018:"Cabazitaxel: FDA-Approved Drugs" 3137: 582: 576: 1312:Therapeutic Advances in Urology 904:European Medicines Agency (EMA) 666:Key:BMQGVNUXMIRLCK-OAGWZNDDSA-N 1749:Thymidylate synthase inhibitor 1639:Thymidylate synthase inhibitor 1047:"First Generic Drug Approvals" 814:of 77.3 h in the third phase. 585: 570: 1: 1669:Adenosine deaminase inhibitor 1510:Block microtubule disassembly 1284:10.1158/1078-0432.CCR-08-0596 1133:10.1158/0008-5472.CAN-11-1417 720:Cabazitaxel was developed by 1167:Journal of Clinical Oncology 1024:Food and Drug Administration 950:Food and Drug Administration 726:Food and Drug Administration 697:, sold under the brand name 724:and was approved by the US 3206: 875:"Jevtana- cabazitaxel kit" 709:inhibitor, and the fourth 560:Chemical and physical data 3088: 2969:Omacetaxine mepesuccinate 2849:Ciltacabtagene autoleucel 2839:Brexucabtagene autoleucel 674: 649: 629: 260: 28: 3021:Talimogene laherparepvec 2954:Nadofaragene firadenovec 2924:Lisocabtagene maraleucel 1873:Topoisomerase inhibitors 1792:DNA polymerase inhibitor 1324:10.1177/1756287214528557 1271:Clinical Cancer Research 1179:10.1200/JCO.2016.72.1068 984:– via PR Newswire. 2824:Axicabtagene ciloleucel 1428:chemotherapeutic agents 3160:Microtubule inhibitors 3006:Sitimagene ceradenovec 2904:Idecabtagene vicleucel 2469:Methyl aminolevulinate 1382:Clinical trial number 1370:Clinical trial number 1358:Clinical trial number 1074:Nature Reviews. Cancer 2480:Porphyrin derivatives 2176:Melphalan flufenamide 1823:Hypomethylating agent 1432:antineoplastic agents 2809:Asparagine depleters 2738:Receptor antagonists 2652:+abiraterone acetate 748:in combination with 713:to be approved as a 2859:Denileukin diftitox 2759:Retinoid X receptor 2459:Aminolevulinic acid 2281:Triethylenemelamine 2113:Crosslinking of DNA 1844:Deoxyribonucleotide 1783:+gimeracil/oteracil 1233:10.2147/DDDT.S13029 930:NCI Drug Dictionary 764:Mechanism of action 224:(Prescription only) 211:(Prescription only) 25: 3165:Mitotic inhibitors 3115:Never to phase III 1917:Etirinotecan pegol 1391:ClinicalTrials.gov 1378:ClinicalTrials.gov 1366:ClinicalTrials.gov 1053:. October 17, 2022 760:-based treatment. 734:generic medication 3190:Tert-Butyl esters 3125: 3124: 3084: 3083: 3041:Tigilanol tiglate 2518:Enzyme inhibitors 2441: 2440: 2437: 2436: 2137:Nitrogen mustards 2107: 2106: 1867: 1866: 1569: 1568: 1173:(28): 3189–3197. 692: 691: 620:Interactive image 510:CompTox Dashboard 247: 232: 219: 206: 138: 105: 16:Chemical compound 3197: 3142: 3141: 3140: 3133: 3046:Tisagenlecleucel 2803:Arsenic trioxide 2514: 2447:Photosensitizers 2238:Alkyl sulfonates 2152:Cyclophosphamide 2124: 2063:Anthracenediones 1884: 1858:Hydroxycarbamide 1599: 1582: 1460: 1420: 1413: 1406: 1397: 1346: 1345: 1335: 1303: 1297: 1296: 1286: 1262: 1256: 1255: 1245: 1235: 1211: 1205: 1204: 1197: 1191: 1190: 1161: 1155: 1154: 1144: 1112: 1106: 1105: 1069: 1063: 1062: 1060: 1058: 1043: 1037: 1036: 1034: 1032: 1014: 1008: 1007: 1005: 1003: 992: 986: 985: 983: 981: 970: 964: 963: 961: 959: 940: 934: 933: 922: 916: 915: 913: 911: 906:. March 17, 2011 896: 890: 889: 887: 885: 871: 860: 859: 857: 855: 845:nctr-crs.fda.gov 837: 798:Pharmacokinetics 688: 687: 680: 622: 602: 587: 584: 578: 572: 555: 544: 533: 532: 518: 516: 501: 481: 461: 454: 434: 414: 394: 374: 354: 344: 343: 329: 245: 242: 237: 230: 227: 217: 214: 204: 201: 179: 136: 133: 115: 104: 101: 88: 74: 33: 26: 24: 3205: 3204: 3200: 3199: 3198: 3196: 3195: 3194: 3175:Benzoate esters 3150: 3149: 3148: 3138: 3136: 3128: 3126: 3121: 3120: 3105:Clinical trials 3080: 2786:Other/ungrouped 2781: 2732: 2505: 2485:Porfimer sodium 2433: 2395: 2328: 2285: 2115: 2103: 1987: 1957: 1875: 1863: 1838: 1734: 1654: 1590: 1588:antimetabolites 1586: 1585:DNA precursors/ 1577: 1575:DNA replication 1565: 1505: 1475:Vinca alkaloids 1451: 1439: 1424: 1355: 1350: 1349: 1305: 1304: 1300: 1264: 1263: 1259: 1213: 1212: 1208: 1199: 1198: 1194: 1163: 1162: 1158: 1127:(18): 6019–29. 1121:Cancer Research 1114: 1113: 1109: 1086:10.1038/nrc1317 1071: 1070: 1066: 1056: 1054: 1045: 1044: 1040: 1030: 1028: 1016: 1015: 1011: 1001: 999: 994: 993: 989: 979: 977: 972: 971: 967: 957: 955: 942: 941: 937: 924: 923: 919: 909: 907: 898: 897: 893: 883: 881: 873: 872: 863: 853: 851: 839: 838: 834: 829: 820: 813: 809: 805: 800: 780:phase III trial 775: 773:Clinical trials 766: 754:prostate cancer 744:Cabazitaxel is 742: 730:prostate cancer 683: 681: 678:(what is this?) 675: 670: 667: 662: 657: 656: 645: 642: 637: 636: 625: 600: 590: 581: 575: 536: 512: 504: 484: 464: 437: 417: 397: 377: 357: 340: 332: 312: 309: 268: 267: 251: 235: 183: 151: 144: 125: 118: 17: 12: 11: 5: 3203: 3201: 3193: 3192: 3187: 3182: 3180:Acetate esters 3177: 3172: 3167: 3162: 3152: 3151: 3147: 3146: 3123: 3122: 3119: 3118: 3117: 3116: 3113: 3102: 3096: 3090: 3089: 3086: 3085: 3082: 3081: 3079: 3078: 3073: 3068: 3063: 3058: 3053: 3048: 3043: 3038: 3033: 3028: 3023: 3018: 3013: 3008: 3003: 2998: 2992: 2981: 2976: 2971: 2966: 2961: 2956: 2951: 2946: 2941: 2936: 2931: 2926: 2921: 2916: 2911: 2906: 2901: 2896: 2891: 2886: 2881: 2876: 2871: 2866: 2861: 2856: 2851: 2846: 2841: 2836: 2831: 2826: 2821: 2805: 2800: 2795: 2789: 2787: 2783: 2782: 2780: 2779: 2767: 2755: 2742: 2740: 2734: 2733: 2731: 2730: 2724: 2719: 2714: 2709: 2697: 2691: 2686: 2681: 2676: 2665: 2659: 2654: 2646: 2639:PARP inhibitor 2635: 2623: 2611: 2599: 2598: 2597: 2592: 2587: 2582: 2570: 2564: 2559: 2554: 2549: 2535: 2522: 2520: 2511: 2507: 2506: 2504: 2503: 2497: 2492: 2487: 2476: 2471: 2466: 2461: 2455: 2453: 2443: 2442: 2439: 2438: 2435: 2434: 2432: 2431: 2425: 2420: 2415: 2405: 2403: 2397: 2396: 2394: 2393: 2387: 2382: 2371: 2366: 2361: 2356: 2344: 2338: 2336: 2330: 2329: 2327: 2326: 2321: 2316: 2311: 2306: 2301: 2295: 2293: 2291:Platinum-based 2287: 2286: 2284: 2283: 2278: 2273: 2268: 2256: 2255: 2249: 2233: 2232: 2227: 2222: 2217: 2207: 2202: 2190: 2189: 2184: 2179: 2169: 2164: 2158: 2149: 2144: 2132: 2130: 2121: 2109: 2108: 2105: 2104: 2102: 2101: 2096: 2091: 2086: 2081: 2075: 2070: 2059: 2053: 2048: 2043: 2038: 2033: 2028: 2018: 2013: 2006:Anthracyclines 2001: 1999: 1989: 1988: 1986: 1985: 1979: 1967: 1965: 1959: 1958: 1956: 1955: 1949: 1944: 1939: 1934: 1929: 1924: 1919: 1914: 1909: 1904: 1892: 1890: 1881: 1869: 1868: 1865: 1864: 1862: 1861: 1848: 1846: 1840: 1839: 1837: 1836: 1830: 1818: 1817: 1804: 1803: 1787: 1786: 1776: 1771: 1766: 1761: 1756: 1744: 1742: 1736: 1735: 1733: 1732: 1726: 1724:Mercaptopurine 1715: 1710: 1705: 1699: 1694: 1678: 1677: 1664: 1662: 1656: 1655: 1653: 1652: 1646: 1635: 1629: 1624: 1619: 1607: 1605: 1596: 1579: 1571: 1570: 1567: 1566: 1564: 1563: 1551: 1545: 1540: 1535: 1530: 1525: 1513: 1511: 1507: 1506: 1504: 1503: 1497: 1492: 1487: 1482: 1470: 1468: 1457: 1441: 1440: 1426:Intracellular 1425: 1423: 1422: 1415: 1408: 1400: 1394: 1393: 1380: 1368: 1354: 1353:External links 1351: 1348: 1347: 1298: 1257: 1206: 1192: 1156: 1107: 1064: 1038: 1009: 987: 965: 954:. July 8, 2013 935: 917: 900:"Jevtana EPAR" 891: 861: 831: 830: 828: 825: 819: 816: 811: 807: 803: 799: 796: 774: 771: 765: 762: 741: 738: 722:Sanofi-Aventis 715:cancer therapy 690: 689: 672: 671: 669: 668: 665: 663: 660: 652: 651: 650: 647: 646: 644: 643: 640: 632: 631: 630: 627: 626: 624: 623: 615: 613: 605: 604: 598: 592: 591: 588: 579: 573: 568: 562: 561: 557: 556: 546: 538: 537: 535: 534: 526:DTXSID40171389 521: 519: 506: 505: 503: 502: 494: 492: 486: 485: 483: 482: 474: 472: 466: 465: 463: 462: 455: 447: 445: 439: 438: 436: 435: 427: 425: 419: 418: 416: 415: 407: 405: 399: 398: 396: 395: 387: 385: 379: 378: 376: 375: 367: 365: 359: 358: 356: 355: 347: 345: 334: 333: 331: 330: 322: 320: 314: 313: 311: 310: 271: 263: 262: 261: 258: 257: 253: 252: 250: 249: 240: 225: 212: 198: 196: 190: 189: 185: 184: 182: 181: 168: 166: 160: 159: 154: 152:administration 146: 145: 143: 142: 140: 130: 128: 120: 119: 117: 116: 98: 96: 90: 89: 82: 76: 75: 68: 58: 57: 54: 50: 49: 46: 40: 39: 35: 34: 15: 13: 10: 9: 6: 4: 3: 2: 3202: 3191: 3188: 3186: 3183: 3181: 3178: 3176: 3173: 3171: 3168: 3166: 3163: 3161: 3158: 3157: 3155: 3145: 3135: 3131: 3114: 3112: 3109: 3108: 3106: 3103: 3100: 3097: 3095: 3092: 3091: 3087: 3077: 3074: 3072: 3069: 3067: 3064: 3062: 3059: 3057: 3054: 3052: 3049: 3047: 3044: 3042: 3039: 3037: 3034: 3032: 3029: 3027: 3024: 3022: 3019: 3017: 3014: 3012: 3009: 3007: 3004: 3002: 2999: 2996: 2993: 2991: 2987: 2986: 2982: 2980: 2979:Tabelecleucel 2977: 2975: 2972: 2970: 2967: 2965: 2962: 2960: 2957: 2955: 2952: 2950: 2947: 2945: 2942: 2940: 2939:Lurbinectedin 2937: 2935: 2932: 2930: 2927: 2925: 2922: 2920: 2917: 2915: 2912: 2910: 2907: 2905: 2902: 2900: 2897: 2895: 2892: 2890: 2887: 2885: 2882: 2880: 2877: 2875: 2872: 2870: 2867: 2865: 2862: 2860: 2857: 2855: 2852: 2850: 2847: 2845: 2842: 2840: 2837: 2835: 2832: 2830: 2827: 2825: 2822: 2819: 2815: 2811: 2810: 2806: 2804: 2801: 2799: 2796: 2794: 2791: 2790: 2788: 2784: 2777: 2773: 2772: 2768: 2765: 2761: 2760: 2756: 2753: 2749: 2748: 2744: 2743: 2741: 2739: 2735: 2728: 2725: 2723: 2720: 2718: 2715: 2713: 2710: 2708: 2704: 2702: 2698: 2695: 2692: 2690: 2687: 2685: 2682: 2680: 2677: 2675: 2671: 2670: 2666: 2663: 2660: 2658: 2655: 2653: 2650: 2647: 2645: 2641: 2640: 2636: 2633: 2629: 2628: 2624: 2621: 2617: 2616: 2612: 2609: 2605: 2604: 2600: 2596: 2593: 2591: 2588: 2586: 2583: 2581: 2578: 2577: 2576: 2575: 2571: 2568: 2565: 2563: 2560: 2558: 2555: 2553: 2550: 2548: 2544: 2543: 2540: 2536: 2533: 2529: 2528: 2524: 2523: 2521: 2519: 2515: 2512: 2508: 2501: 2498: 2496: 2493: 2491: 2488: 2486: 2482: 2481: 2477: 2475: 2472: 2470: 2467: 2465: 2462: 2460: 2457: 2456: 2454: 2452: 2448: 2444: 2429: 2426: 2424: 2421: 2419: 2416: 2414: 2410: 2407: 2406: 2404: 2402: 2401:Intercalation 2398: 2391: 2388: 2386: 2383: 2381: 2377: 2376: 2372: 2370: 2367: 2365: 2362: 2360: 2357: 2354: 2350: 2349: 2345: 2343: 2340: 2339: 2337: 2335: 2331: 2325: 2322: 2320: 2317: 2315: 2312: 2310: 2309:Dicycloplatin 2307: 2305: 2302: 2300: 2297: 2296: 2294: 2292: 2288: 2282: 2279: 2277: 2274: 2272: 2269: 2267: 2264: 2262: 2258: 2257: 2253: 2250: 2248: 2244: 2241: 2239: 2235: 2234: 2231: 2228: 2226: 2223: 2221: 2218: 2215: 2211: 2208: 2206: 2203: 2201: 2198: 2196: 2192: 2191: 2188: 2185: 2183: 2182:Prednimustine 2180: 2177: 2173: 2170: 2168: 2165: 2162: 2159: 2157: 2153: 2150: 2148: 2145: 2143: 2140: 2138: 2134: 2133: 2131: 2129: 2125: 2122: 2119: 2114: 2110: 2100: 2097: 2095: 2092: 2090: 2087: 2085: 2082: 2079: 2076: 2074: 2071: 2069: 2065: 2064: 2060: 2057: 2054: 2052: 2049: 2047: 2044: 2042: 2039: 2037: 2034: 2032: 2029: 2026: 2022: 2019: 2017: 2014: 2012: 2008: 2007: 2003: 2002: 2000: 1998: 1997:Intercalation 1994: 1990: 1983: 1980: 1978: 1974: 1973: 1969: 1968: 1966: 1964: 1960: 1953: 1950: 1948: 1945: 1943: 1940: 1938: 1935: 1933: 1930: 1928: 1925: 1923: 1920: 1918: 1915: 1913: 1910: 1908: 1905: 1903: 1899: 1898: 1894: 1893: 1891: 1889: 1885: 1882: 1879: 1874: 1870: 1859: 1855: 1854: 1850: 1849: 1847: 1845: 1841: 1834: 1831: 1829: 1825: 1824: 1820: 1819: 1815: 1811: 1810: 1806: 1805: 1801: 1800:+daunorubicin 1798: 1794: 1793: 1789: 1788: 1784: 1780: 1777: 1775: 1772: 1770: 1767: 1765: 1764:Doxifluridine 1762: 1760: 1757: 1755: 1751: 1750: 1746: 1745: 1743: 1741: 1737: 1730: 1727: 1725: 1721: 1720: 1716: 1714: 1713:Rabacfosadine 1711: 1709: 1706: 1703: 1700: 1698: 1695: 1693: 1689: 1688: 1684: 1680: 1679: 1675: 1671: 1670: 1666: 1665: 1663: 1661: 1657: 1650: 1647: 1645: 1641: 1640: 1636: 1633: 1630: 1628: 1625: 1623: 1620: 1618: 1614: 1613: 1609: 1608: 1606: 1604: 1600: 1597: 1594: 1589: 1583: 1580: 1576: 1572: 1561: 1557: 1556: 1552: 1549: 1546: 1544: 1541: 1539: 1536: 1534: 1531: 1529: 1526: 1524: 1520: 1519: 1515: 1514: 1512: 1508: 1501: 1498: 1496: 1493: 1491: 1488: 1486: 1483: 1481: 1477: 1476: 1472: 1471: 1469: 1466: 1461: 1458: 1455: 1450: 1446: 1442: 1437: 1433: 1429: 1421: 1416: 1414: 1409: 1407: 1402: 1401: 1398: 1392: 1387: 1386: 1381: 1379: 1375: 1374: 1369: 1367: 1363: 1362: 1357: 1356: 1352: 1343: 1339: 1334: 1329: 1325: 1321: 1318:(3): 97–104. 1317: 1313: 1309: 1302: 1299: 1294: 1290: 1285: 1280: 1277:(2): 723–30. 1276: 1272: 1268: 1261: 1258: 1253: 1249: 1244: 1239: 1234: 1229: 1225: 1221: 1217: 1210: 1207: 1202: 1196: 1193: 1188: 1184: 1180: 1176: 1172: 1168: 1160: 1157: 1152: 1148: 1143: 1138: 1134: 1130: 1126: 1122: 1118: 1111: 1108: 1103: 1099: 1095: 1091: 1087: 1083: 1080:(4): 253–65. 1079: 1075: 1068: 1065: 1052: 1048: 1042: 1039: 1027: 1025: 1019: 1013: 1010: 997: 991: 988: 975: 969: 966: 953: 951: 945: 939: 936: 931: 927: 926:"Cabazitaxel" 921: 918: 905: 901: 895: 892: 880: 876: 870: 868: 866: 862: 850: 846: 842: 836: 833: 826: 824: 817: 815: 797: 795: 793: 789: 785: 781: 772: 770: 763: 761: 759: 755: 751: 747: 739: 737: 735: 731: 727: 723: 718: 716: 712: 708: 704: 700: 696: 686: 679: 673: 664: 659: 655: 648: 639: 635: 628: 621: 617: 616: 614: 611: 606: 599: 597: 593: 569: 567: 563: 558: 554: 550: 547: 545: 543:ECHA InfoCard 539: 531: 527: 523: 522: 520: 511: 507: 500: 499:ChEMBL1201748 496: 495: 493: 491: 487: 480: 476: 475: 473: 471: 467: 460: 456: 453: 449: 448: 446: 444: 440: 433: 429: 428: 426: 424: 420: 413: 409: 408: 406: 404: 400: 393: 389: 388: 386: 384: 380: 373: 369: 368: 366: 364: 360: 353: 349: 348: 346: 339: 335: 328: 324: 323: 321: 319: 315: 307: 303: 299: 295: 291: 287: 283: 279: 275: 270: 266: 259: 254: 248: Rx-only 241: 238: 226: 223: 213: 210: 200: 199: 197: 195: 191: 186: 178: 173: 170: 169: 167: 165: 161: 158: 155: 153: 147: 141: 132: 131: 129: 127: 121: 114: 109: 100: 99: 97: 95: 91: 87: 83: 81: 77: 73: 69: 67: 63: 59: 55: 51: 47: 45: 41: 38:Clinical data 36: 32: 27: 19: 3026:Tazemetostat 2990:Alitretinoin 2983: 2894:Estramustine 2874:Elsamitrucin 2864:Eflornithine 2818:Pegaspargase 2814:Asparaginase 2807: 2776:Testolactone 2769: 2757: 2745: 2699: 2684:Panobinostat 2667: 2637: 2625: 2613: 2601: 2572: 2537: 2525: 2478: 2474:Padeliporfin 2413:Dactinomycin 2409:Streptomyces 2390:Temozolomide 2385:Mitozolomide 2373: 2364:Mitobronitol 2353:Procarbazine 2346: 2334:Nonclassical 2259: 2236: 2230:Streptozocin 2195:Nitrosoureas 2193: 2167:Chlorambucil 2161:Trofosfamide 2147:Chlormethine 2142:Bendamustine 2135: 2073:Mitoxantrone 2068:Losoxantrone 2061: 2021:Daunorubicin 2004: 1970: 1907:Camptothecin 1895: 1851: 1821: 1807: 1790: 1774:Fluorouracil 1754:Capecitabine 1747: 1717: 1681: 1667: 1637: 1632:Pralatrexate 1622:Methotrexate 1610: 1553: 1522: 1516: 1473: 1383: 1371: 1359: 1315: 1311: 1301: 1274: 1270: 1260: 1223: 1219: 1209: 1195: 1170: 1166: 1159: 1124: 1120: 1110: 1077: 1073: 1067: 1057:November 28, 1055:. Retrieved 1050: 1041: 1031:December 30, 1029:. Retrieved 1021: 1012: 1002:December 30, 1000:. Retrieved 990: 980:December 30, 978:. Retrieved 968: 958:December 30, 956:. Retrieved 947: 938: 929: 920: 908:. Retrieved 903: 894: 884:December 30, 882:. Retrieved 878: 852:. Retrieved 844: 835: 821: 801: 788:mitoxantrone 776: 767: 743: 740:Medical uses 719: 698: 694: 693: 682:   676:   305: 301: 297: 293: 289: 285: 281: 277: 273: 194:Legal status 188:Legal status 94:License data 18: 3101:from market 3071:Vorasidenib 3051:Trabectedin 3036:Tiazofurine 3031:Tebentafusp 3016:Tagraxofusp 2974:Plitidepsin 2944:Mitoguazone 2884:Epacadostat 2854:Demecolcine 2798:Aflibercept 2771:Sex steroid 2644:Fuzuloparib 2585:Carfilzomib 2557:Palbociclib 2547:Abemaciclib 2500:Verteporfin 2464:Efaproxiral 2380:Dacarbazine 2342:Altretamine 2324:Satraplatin 2319:Oxaliplatin 2299:Carboplatin 2276:Triaziquone 2247:Mannosulfan 2225:Ranimustine 2205:Fotemustine 2046:Pirarubicin 2031:Doxorubicin 2025:+cytarabine 2011:Aclarubicin 1972:Podophyllum 1897:Camptotheca 1828:Azacitidine 1814:Gemcitabine 1769:Floxuridine 1702:Fludarabine 1697:Clofarabine 1683:Halogenated 1674:Pentostatin 1649:Raltitrexed 1617:Aminopterin 1560:Ixabepilone 1555:Epothilones 1523:Cabazitaxel 1500:Vinorelbine 1485:Vincristine 1480:Vinblastine 1465:microtubule 1385:NCT02485691 1373:NCT01308580 1361:NCT00417079 854:October 22, 792:neutropenia 707:microtubule 695:Cabazitaxel 603: g·mol 549:100.205.741 479:CHEBI:63584 327:183133-96-2 256:Identifiers 157:Intravenous 113:Cabazitaxel 80:MedlinePlus 53:Other names 44:Trade names 23:Cabazitaxel 3170:Carbamates 3154:Categories 3066:Verdinexor 3061:Venetoclax 2964:Oblimersen 2959:Navitoclax 2934:Lucanthone 2929:Lonidamine 2919:Lifileucel 2914:Ivosidenib 2909:Imetelstat 2879:Enasidenib 2869:Elesclomol 2834:Bexarotene 2829:Belzutifan 2764:Bexarotene 2752:Atrasentan 2727:Umbralisib 2722:Idelalisib 2712:Copanlisib 2694:Vorinostat 2689:Romidepsin 2679:Entinostat 2674:Belinostat 2632:Masoprocol 2620:Tiazofurin 2608:Anagrelide 2580:Bortezomib 2567:Seliciclib 2562:Ribociclib 2542:inhibitors 2532:Tipifarnib 2495:Temoporfin 2490:Talaporfin 2428:Plicamycin 2423:Mitomycins 2369:Pipobroman 2348:Hydrazines 2314:Nedaplatin 2266:Carboquone 2261:Aziridines 2252:Treosulfan 2200:Carmustine 2187:Uramustine 2156:Ifosfamide 2128:Alkylating 2089:Bisantrene 2078:Pixantrone 2051:Valrubicin 2041:Idarubicin 2036:Epirubicin 1982:Teniposide 1937:Lurtotecan 1932:Irinotecan 1833:Decitabine 1797:Cytarabine 1740:Pyrimidine 1729:Tioguanine 1719:Thiopurine 1708:Nelarabine 1692:Cladribine 1644:Pemetrexed 1627:Pemetrexed 1603:Folic acid 1543:Paclitaxel 1495:Vinflunine 1226:: 117–24. 910:August 10, 827:References 818:Metabolism 756:following 750:prednisone 705:. It is a 608:3D model ( 596:Molar mass 432:51F690397J 403:ChemSpider 363:IUPHAR/BPS 318:CAS Number 265:IUPAC name 3111:Phase III 3099:Withdrawn 3076:Vosaroxin 3056:Veliparib 3011:Sotorasib 3001:Selinexor 2995:Tretinoin 2985:Retinoids 2899:Glasdegib 2844:Celecoxib 2793:Adagrasib 2717:Duvelisib 2707:Alpelisib 2662:Rucaparib 2649:Niraparib 2590:Oprozomib 2552:Alvocidib 2418:Bleomycin 2375:Triazenes 2359:Etoglucid 2304:Cisplatin 2220:Nimustine 2214:Semustine 2210:Lomustine 2172:Melphalan 2099:Menogaril 2094:Crisnatol 2084:Amsacrine 2056:Zorubicin 2016:Amrubicin 1977:Etoposide 1952:Topotecan 1947:Silatecan 1942:Rubitecan 1927:Gimatecan 1912:Cositecan 1902:Belotecan 1578:inhibitor 1548:Tesetaxel 1538:Ortataxel 1533:Larotaxel 1528:Docetaxel 1490:Vindesine 758:docetaxel 746:indicated 150:Routes of 124:Pregnancy 72:Monograph 66:Drugs.com 3144:Medicine 2949:Mitotane 2889:Eribulin 2657:Olaparib 2595:Ixazomib 2271:Thiotepa 2243:Busulfan 1922:Exatecan 1759:Carmofur 1467:assembly 1430: / 1342:24883107 1293:19147780 1252:21448449 1187:28753384 1151:21799031 1102:10228718 1094:15057285 879:DailyMed 685:(verify) 383:DrugBank 164:ATC code 126:category 108:DailyMed 56:XRP-6258 3185:Taxanes 1878:S phase 1779:Tegafur 1593:S phase 1518:Taxanes 1454:M phase 1333:4003844 1243:3063116 1142:3354631 699:Jevtana 601:835.944 566:Formula 412:8029779 392:DB06772 352:9854073 338:PubChem 239:Rx-only 236:WARNING 180:) 174: ( 172:L01CD04 139: D 110::  86:a611009 48:Jevtana 3130:Portal 3094:WHO-EM 2703:(Pi3K) 1660:Purine 1463:Block 1340:  1330:  1291:  1250:  1240:  1185:  1149:  1139:  1100:  1092:  711:taxane 703:taxoid 634:SMILES 490:ChEMBL 459:D10452 452:D09755 233: 220: 207: 106:  2615:IMPDI 2510:Other 1098:S2CID 1026:(FDA) 1022:U.S. 952:(FDA) 948:U.S. 654:InChI 610:JSmol 470:ChEBI 2701:PIKI 2669:HDAC 2118:CCNS 1338:PMID 1289:PMID 1248:PMID 1183:PMID 1147:PMID 1090:PMID 1059:2022 1033:2021 1004:2021 982:2021 960:2021 912:2024 886:2021 856:2023 443:KEGG 423:UNII 372:6798 62:AHFS 2747:ERA 2603:PhI 2574:PrI 2539:CDK 2451:PDT 1449:MIs 1445:SPs 1436:L01 1328:PMC 1320:doi 1279:doi 1238:PMC 1228:doi 1175:doi 1137:PMC 1129:doi 1082:doi 849:FDA 812:1/2 808:1/2 804:1/2 515:EPA 342:CID 304:,15 300:,12 296:,10 222:POM 177:WHO 3156:: 3107:: 2627:LI 2527:FI 1993:II 1963:II 1785:)) 1336:. 1326:. 1314:. 1310:. 1287:. 1275:15 1273:. 1269:. 1246:. 1236:. 1222:. 1218:. 1181:. 1171:35 1169:. 1145:. 1135:. 1125:71 1123:. 1119:. 1096:. 1088:. 1076:. 1049:. 1020:. 946:. 928:. 902:. 877:. 864:^ 847:. 843:. 736:. 717:. 589:14 580:57 574:45 292:,9 288:,7 284:,4 280:,3 276:,2 272:(1 244:EU 229:US 216:UK 209:S4 203:AU 135:AU 103:US 3132:: 2997:) 2988:( 2820:) 2816:/ 2812:( 2778:) 2774:( 2766:) 2762:( 2754:) 2750:( 2729:) 2705:( 2696:) 2672:( 2664:) 2642:( 2634:) 2630:( 2622:) 2618:( 2610:) 2606:( 2569:) 2545:( 2534:) 2530:( 2502:) 2483:( 2449:/ 2430:) 2411:( 2392:) 2378:( 2355:) 2351:( 2263:: 2254:) 2245:( 2240:: 2216:) 2212:( 2197:: 2178:) 2174:( 2163:) 2154:( 2139:: 2120:) 2116:( 2080:) 2066:( 2058:) 2027:) 2023:( 2009:( 1995:+ 1984:) 1975:( 1954:) 1900:( 1888:I 1880:) 1876:( 1860:) 1856:( 1835:) 1826:( 1816:) 1812:( 1802:) 1795:( 1781:( 1752:( 1731:) 1722:( 1704:) 1690:( 1685:/ 1676:) 1672:( 1651:) 1642:( 1634:) 1615:( 1595:) 1591:( 1562:) 1558:( 1550:) 1521:( 1502:) 1478:( 1456:) 1452:( 1447:/ 1438:) 1434:( 1419:e 1412:t 1405:v 1344:. 1322:: 1316:6 1295:. 1281:: 1254:. 1230:: 1224:5 1203:. 1189:. 1177:: 1153:. 1131:: 1104:. 1084:: 1078:4 1061:. 1035:. 1006:. 962:. 914:. 888:. 858:. 612:) 586:O 583:N 577:H 571:C 517:) 513:( 306:S 302:R 298:S 294:S 290:R 286:S 282:R 278:S 274:S 246:: 231:: 218:: 205:: 137:: 64:/

Index


Trade names
AHFS
Drugs.com
Monograph
MedlinePlus
a611009
License data
DailyMed
Cabazitaxel
Pregnancy
category

Routes of
administration

Intravenous
ATC code
L01CD04
WHO
Legal status
S4
POM
WARNING
IUPAC name
CAS Number
183133-96-2
PubChem
9854073
IUPHAR/BPS
6798
DrugBank
DB06772
ChemSpider

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.